Pacific Edge Limited (PEB.AX)
AUD 0.14
(0.0%)
AUD 0.14
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -50.62 Million NZD | 67.58% |
| 2023 | -76.56 Million NZD | 26.01% |
| 2022 | -103.48 Million NZD | -8172.5% |
| 2021 | -1.25 Million NZD | -522.39% |
| 2020 | -201 Thousand NZD | 95.78% |
| 2019 | -4.76 Million NZD | 7.39% |
| 2018 | -5.14 Million NZD | 64.69% |
| 2017 | -14.56 Million NZD | 39.72% |
| 2016 | -24.16 Million NZD | -209.0% |
| 2015 | -7.81 Million NZD | 61.75% |
| 2014 | -20.44 Million NZD | -94.27% |
| 2013 | -10.52 Million NZD | 40.77% |
| 2012 | -17.76 Million NZD | -674.09% |
| 2011 | -2.29 Million NZD | -199.9% |
| 2010 | -765.37 Thousand NZD | -1107.69% |
| 2009 | -63.37 Thousand NZD | 97.46% |
| 2008 | -2.49 Million NZD | -4664.9% |
| 2007 | -52.34 Thousand NZD | 90.62% |
| 2006 | -557.82 Thousand NZD | -315.3% |
| 2005 | -134.31 Thousand NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -19.58 Million NZD | 0.0% |
| 2024 Q3 | -26.45 Million NZD | -35.06% |
| 2024 Q4 | -50.62 Million NZD | 6.17% |
| 2024 Q1 | -19.58 Million NZD | 74.42% |
| 2024 FY | -50.62 Million NZD | 33.89% |
| 2023 Q2 | -37.32 Million NZD | 0.0% |
| 2023 Q4 | -76.56 Million NZD | -133.31% |
| 2023 FY | -76.56 Million NZD | 26.01% |
| 2023 Q3 | -32.81 Million NZD | 12.08% |
| 2023 Q1 | -37.32 Million NZD | 63.93% |
| 2022 Q3 | -34.56 Million NZD | 56.12% |
| 2022 Q4 | -103.48 Million NZD | -199.44% |
| 2022 FY | -103.48 Million NZD | -8172.5% |
| 2022 Q1 | -78.76 Million NZD | -6196.24% |
| 2022 Q2 | -78.76 Million NZD | 0.0% |
| 2021 FY | -1.25 Million NZD | -522.39% |
| 2021 Q2 | -3.16 Million NZD | 0.0% |
| 2021 Q1 | -3.16 Million NZD | 76.05% |
| 2021 Q4 | -1.25 Million NZD | 46.74% |
| 2021 Q3 | -2.34 Million NZD | 25.85% |
| 2020 Q1 | -2.38 Million NZD | 81.31% |
| 2020 Q4 | -13.23 Million NZD | -1017.4% |
| 2020 Q2 | -2.38 Million NZD | 0.0% |
| 2020 Q3 | -1.18 Million NZD | 50.36% |
| 2020 FY | -201 Thousand NZD | 95.78% |
| 2019 Q1 | -4.51 Million NZD | 72.05% |
| 2019 FY | -4.76 Million NZD | 7.39% |
| 2019 Q4 | -12.76 Million NZD | -165.07% |
| 2019 Q3 | -4.81 Million NZD | -6.72% |
| 2019 Q2 | -4.51 Million NZD | 0.0% |
| 2018 Q1 | -3.94 Million NZD | 72.93% |
| 2018 FY | -5.14 Million NZD | 64.69% |
| 2018 Q4 | -16.14 Million NZD | -209.49% |
| 2018 Q3 | -5.21 Million NZD | -32.29% |
| 2018 Q2 | -3.94 Million NZD | 0.0% |
| 2017 Q1 | -4.6 Million NZD | 80.94% |
| 2017 FY | -14.56 Million NZD | 39.72% |
| 2017 Q4 | -14.56 Million NZD | -121.88% |
| 2017 Q3 | -6.56 Million NZD | -42.57% |
| 2017 Q2 | -4.6 Million NZD | 0.0% |
| 2016 Q3 | -4.16 Million NZD | -11.81% |
| 2016 Q4 | -24.16 Million NZD | -480.72% |
| 2016 FY | -24.16 Million NZD | -209.0% |
| 2016 Q1 | -3.72 Million NZD | 52.41% |
| 2016 Q2 | -3.72 Million NZD | 0.0% |
| 2015 FY | -7.81 Million NZD | 61.75% |
| 2015 Q1 | -4.7 Million NZD | 76.98% |
| 2015 Q4 | -7.81 Million NZD | -177.38% |
| 2015 Q3 | -2.81 Million NZD | 40.12% |
| 2015 Q2 | -4.7 Million NZD | 0.0% |
| 2014 Q2 | -6.38 Million NZD | 0.0% |
| 2014 FY | -20.44 Million NZD | -94.27% |
| 2014 Q4 | -20.44 Million NZD | -313.53% |
| 2014 Q3 | -4.94 Million NZD | 22.52% |
| 2014 Q1 | -6.38 Million NZD | 39.37% |
| 2013 Q3 | -6.48 Million NZD | 0.0% |
| 2013 FY | -10.52 Million NZD | 40.77% |
| 2013 Q4 | -10.52 Million NZD | -62.38% |
| 2012 Q4 | -17.76 Million NZD | 0.0% |
| 2012 FY | -17.76 Million NZD | -674.09% |
| 2011 FY | -2.29 Million NZD | -199.9% |
| 2011 Q4 | -2.29 Million NZD | 0.0% |
| 2010 FY | -765.37 Thousand NZD | -1107.69% |
| 2010 Q4 | -765.78 Thousand NZD | 0.0% |
| 2009 Q4 | -63.03 Thousand NZD | 0.0% |
| 2009 FY | -63.37 Thousand NZD | 97.46% |
| 2008 FY | -2.49 Million NZD | -4664.9% |
| 2008 Q4 | -2.49 Million NZD | 0.0% |
| 2007 FY | -52.34 Thousand NZD | 90.62% |
| 2006 FY | -557.82 Thousand NZD | -315.3% |
| 2005 FY | -134.31 Thousand NZD | 0.0% |
| 2005 Q4 | -134.39 Thousand NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 282.76 Million AUD | 117.903% |
| BCAL Diagnostics Limited | -5.83 Million AUD | -768.083% |
| Genetic Signatures Limited | -35.03 Million AUD | -44.511% |
| Genetic Technologies Limited | -377.06 Thousand AUD | -13325.795% |
| Healius Limited | 1.53 Billion AUD | 103.292% |
| Imagion Biosystems Limited | 5.81 Million AUD | 971.129% |
| Integral Diagnostics Limited | 315.35 Million AUD | 116.053% |
| INOVIQ Ltd | -8.69 Million AUD | -482.005% |
| Microba Life Sciences Limited | -20.49 Million AUD | -147.016% |
| Monash IVF Group Limited | 48.23 Million AUD | 204.958% |
| Rhythm Biosciences Limited | -545.67 Thousand AUD | -9177.255% |
| Sonic Healthcare Limited | 3.87 Billion AUD | 101.308% |